MBA from Cornell University (US); Bachelor from Zhongshan University
Over 20 years of experience in multinational companies and the investment sector. Previously held senior positions at Syngenta, Eaton China, A.T.Kearney, General Electric, Philips and Shell.
Managing Director, CXC Capital
Senior VP, GL Capital
China Head, Olympus Capital
Awards and Honors
Top 50 The Most Influential Investors, 2021 CHC China Healthcare Industry Investment and Financial Honor List
Top 100 Best Investors, 2021 Person of The Year by Qi Ming Pian
Top 10 Best Investors, 2021 Healthcare Investment by LP Club
Best Healthcare Investor, the 5th Healthcare Investment Excellent List by Haoyue Capital
Ascentage Pharma (6855.HK), Henlius Biotech (2696.HK), Kintor Pharma (9939.HK), Basecare Medical (2170.HK), BrightGene (688166), Allist Pharma (688578), Kawin Technology (688687), Nano-Micro (688690), YHLO Biotech (688575), ShengNuo Biotech (688117), Zylox-Tonbridge (2190.HK), Quantum-Si (NASDAQ), Creative Sciences, PegBio, Smartee, Capitalbio Technology, Innovita, Lifereal, Ark Biosciences, Jingfeng Pharma (000908), BGI Genomics (300676), Kangning Hospital (2120.HK) etc.